Patient with generalized melanoma treated with nivolumab with long-term response after previous failure of combined chemotherapy

02/2019

MUDr. Taťána Šuková

Dermatovenerologická klinika VFN a 1. LF UK, Praha

 

SUMMARY

Treatment of advances malignant melanoma has seen significant changes in recent years. After decades of stagnation when chemotherapy was used to treat metastatic melanoma the efficacy of which is limited in this tumor, two new drug regimens are now available - advanced imunotherapy offer the chance of long-term survival of nearly 30% of patients.

 

Key words

melanoma, modern imunotherapy, nivolumab

 

 

Celý článek je dostupný pouze pro předplatitele

Staňte se pravidelným odběratelem našeho časopisu Onkologická revue...

 

VÍCE O PŘEDPLATNÉM